Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Levetiracetam and Carbamazepine Impact the Autonomic Activity of Children With Self-limiting Focal Epilepsy?

NCT06138847 is registered in ClinicalTrials.gov with İpek Dokurel as lead sponsor.

NCT NCT06138847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06138847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Levetiracetam and Carbamazepine Impact the Autonomic Activity of Children With Self-limiting Focal Epilepsy?
Lead sponsor
İpek Dokurel
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2023
Completion date
December 2, 2023
Enrollment
119 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy; syndrome, seizures of localized onset